Topics

AbbVie ducks bolt-on trend and agrees Allergan mega-merger

12:09 EDT 25 Jun 2019 | pharmaphorum

US drugmaker AbbVie has agreed to buy struggling Allergan in a $63 billion deal that continues a slew of multibillion dollar takeovers in the biopharma sector this year. AbbVie is stumping up more than $188 per share for Ireland-domiciled Allergan,...

Original Article: AbbVie ducks bolt-on trend and agrees Allergan mega-merger

NEXT ARTICLE

More From BioPortfolio on "AbbVie ducks bolt-on trend and agrees Allergan mega-merger"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...